These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Genomic searches for genes that influence atherosclerosis and its risk factors. Hixson JE; Blangero J Ann N Y Acad Sci; 2000 May; 902():1-7. PubMed ID: 10865820 [TBL] [Abstract][Full Text] [Related]
45. Triglyceride-rich lipoproteins: are links with atherosclerosis mediated by a procoagulant and proinflammatory phenotype? Byrne CD Atherosclerosis; 1999 Jul; 145(1):1-15. PubMed ID: 10428291 [TBL] [Abstract][Full Text] [Related]
46. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Paigen B; Mitchell D; Reue K; Morrow A; Lusis AJ; LeBoeuf RC Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3763-7. PubMed ID: 3473481 [TBL] [Abstract][Full Text] [Related]
47. Apolipoprotein E polymorphism and atherosclerosis. Davignon J; Gregg RE; Sing CF Arteriosclerosis; 1988; 8(1):1-21. PubMed ID: 3277611 [TBL] [Abstract][Full Text] [Related]
49. Genetic susceptibility to atherosclerosis. Chamberlain JC; Galton DJ Br Med Bull; 1990 Oct; 46(4):917-40. PubMed ID: 1983134 [TBL] [Abstract][Full Text] [Related]
50. Lipoproteins and the pathogenesis of atherosclerosis. Steinberg D Circulation; 1987 Sep; 76(3):508-14. PubMed ID: 3621517 [TBL] [Abstract][Full Text] [Related]
51. Intermediate density lipoprotein levels are strong predictors of the extent of aortic atherosclerosis in the St. Thomas's Hospital rabbit strain. Nordestgaard BG; Lewis B Atherosclerosis; 1991 Mar; 87(1):39-46. PubMed ID: 1872923 [TBL] [Abstract][Full Text] [Related]
52. LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits. Brousseau ME; Kauffman RD; Herderick EE; Demosky SJ; Evans W; Marcovina S; Santamarina-Fojo S; Brewer HB; Hoeg JM Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):450-8. PubMed ID: 10669643 [TBL] [Abstract][Full Text] [Related]
54. Apolipoproteins and atherosclerosis. Apolipoprotein E and apolipoprotein(a) as candidate genes of premature development of atherosclerosis. Horejsí B; Ceska R Physiol Res; 2000; 49 Suppl 1():S63-9. PubMed ID: 10984073 [TBL] [Abstract][Full Text] [Related]
55. [Molecular medicine and gene therapy as exemplified with arteriosclerosis and restenosis]. Lüscher TF; Oemar BS; Yang Z; Noll G Schweiz Med Wochenschr; 1995 Nov; 125(44):2107-21. PubMed ID: 7502010 [TBL] [Abstract][Full Text] [Related]
56. Predictive genetic testing to control coronary heart disease and hyperlipidemia. Berg K Arteriosclerosis; 1989; 9(1 Suppl):I50-8. PubMed ID: 2521445 [TBL] [Abstract][Full Text] [Related]
57. Splice-site mutations in atherosclerosis candidate genes: relating individual information to phenotype. von Kodolitsch Y; Pyeritz RE; Rogan PK Circulation; 1999 Aug; 100(7):693-9. PubMed ID: 10449689 [TBL] [Abstract][Full Text] [Related]
59. Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. Nishina PM; Johnson JP; Naggert JK; Krauss RM Proc Natl Acad Sci U S A; 1992 Jan; 89(2):708-12. PubMed ID: 1731344 [TBL] [Abstract][Full Text] [Related]